Posted: 27 June 2024
Participants in clinical trials get early access to these potentially life-saving new therapies, while at the same time advancing medical knowledge. More broadly, clinical trial activity contributes to the development of a thriving research culture within Australia’s healthcare system and promotes Australia’s international research profile.
A global reputation for clinical trials excellence has made Australia a go-to destination for companies wanting to conduct clinical trials and seen the clinical trials sector develop into one of the country’s most important and valuable services exports.
This report, Australia’s Clinical Trials Sector: Advancing innovative healthcare and powering economic growth, developed through extensive and whole-of-sector stakeholder engagement, provides a snapshot of the size and scope of Australia’s clinical trials sector. It examines how the sector is performing, highlights the significant contribution that the conduct of clinical trials makes to the Australian economy and better health outcomes, and identifies opportunities for future growth.
Key findings:
- $1.6 billion contributed to the Australian economy in 2022
- Employs more than 7,700 Australians
- 90,000 Australians participated in clinical trials in 2022
- 1,850 trials started in 2022
This new report follows two comprehensive sector profiles previously published by MTPConnect in 2021 and 2017 – all three serve as important resources for the sector.
These reports have been produced in collaboration with L.E.K Consulting.
